MOLECULAR ANALYSIS OF PLASMODIUM VIVAX SURFACE ANTIGENS
MOLECULAR ANALYSIS OF PLASMODIUM VIVAX SURFACE ANTIGENS
批准号:
8172324
负责人:
MARY R GALINSKI
金额:
$5.48万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-05-01 至 2011-04-30
关键词:
AffectAntibodiesApicalBindingBinding ProteinsBiologicalBiological AssayBiologyBloodComplexComputer Retrieval of Information on Scientific Projects DatabaseDataDevelopmentErythrocytesFamilyFundingGene Expression ProfileGene ProteinsGrantHumanImmune responseImmunoelectron MicroscopyIn VitroInstitutionInvestigationLocationMacaca mulattaMalariaManuscriptsMediatingModelingMolecularMolecular AnalysisPlasmodiumPlasmodium falciparumPlasmodium vivaxPreparationProcessProtein FamilyProteinsProteomePublishingReagentRecombinant DNAReportingResearchResearch PersonnelResourcesRoleSourceStagingStructureSurface AntigensTechnologyTestingUnited States National Institutes of HealthVaccinesdesignknockout genemembernonhuman primatenovelreceptorvaccine development
中文摘要
这个子项目是许多研究子项目中利用
资源由NIH/NCRR资助的中心拨款提供。子项目和
调查员(PI)可能从NIH的另一个来源获得了主要资金,
并因此可以在其他清晰的条目中表示。列出的机构是
该中心不一定是调查人员的机构。
这项研究的长期目标是提供基本的分子生物学和免疫生物学信息,以支持针对间日疟原虫的血液期疫苗的开发,间日疟原虫是人类疟疾最流行的两个物种之一。这项研究也有助于增进对恶性疟原虫生物学的了解,恶性疟原虫是人类疟疾的另一个主要物种。感染恒河猴的相关非人类灵长类疟原虫食蟹猴疟原虫、柯氏疟原虫和诺氏疟原虫是这些研究的极佳模型。该项目需要对几种疟原虫裂殖子蛋白及其编码基因进行表征,重点是1)在裂殖子侵入红细胞的受体介导的过程中具有明显的直接或间接功能的分子,以及2)可能通过刺激抗间日疟原虫而影响间日疟原虫与人类之间的免疫生物学关系的分子。间日疟原虫免疫反应。
配合使用体外裂殖子侵袭和附着分析、免疫电子显微镜、基因敲除技术、确定的抗体和重组DNA试剂,以及使用猴疟疾模型,有助于精确确定和澄清所研究的裂殖子蛋白的位置、功能、结构和可能的相互作用关系。今年,我们发表了诺氏疟原虫正常细胞结合蛋白家族的鉴定报告,发现了PkNBP红细胞结合结构域、PV和PK Rhop H复合体、11个成员的PV MSP3家族和食蟹猴P.phist蛋白及其家族的手稿正在提交中。一份定义一种新的裂殖子顶端蛋白(MAP)的手稿正在准备中。
今年,还生成了大量的转录组和蛋白质组数据,目前正在进行分析,为手稿和新方向的设计做准备。此外,已经发表了三篇综述,并为嵌合疫苗开发和测试研究提供了支持。
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
The long-term objective of this research is to provide fundamental molecular biological and immunobiological information tosupport the development of a blood-stage vaccine against Plasmodium vivax, one of the two most prevalent species of human malaria. This research is also relevant for increasing the understanding of the biology of P. falciparum, the other major species of human malaria. The related non-human primate malarias P. cynomolgi, P. coatneyi and P. knowlesi, which infected rhesus monkeys, are excellent models for these investigations. This project entails the characterization of several Plasmodium merozoite proteins and the genes encoding them, with emphasis on molecules that 1) have an apparent direct or indirect function in the receptor mediated processes of merozoite invasion of erythrocytes, and 2) are likely to have a role in affecting the immunobiological relationship between P. vivax and humans by stimulating anti-P. vivax immune responses.
The coordinated use of in-vitro merozoite invasion and attachment assays, immunoelectron microscopy, gene knockout technologies, defined antibody and recombinant DNA reagents, and the use of the simian malaria models, aid in the precise determination and clarification of the location(s), function, structure and possible interactive relationships of the merozoite proteins under investigation. This year, our report on the identification of the normocyte binding protein family in P. knowlesi was published, and manuscripts on the discovery of a PkNBP erythrocyte binding domain, the Pv and Pk RhopH complex, the 11 member Pv MSP3 family, and P. cynomolgi PHIST protein and family are under review for submission. A manuscript defining a novel merozoite apical protein (MAP) is being prepared.
This year, extensive transcriptome and proteome data have also been generated and analyzes are underway in preparation for manuscripts and the design of new directions. Further, three reviews have been published and support provided for a study on chimeric vaccine development and testing.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Integrated Approach to Host-Pathogen Interactions
-
批准号:8564414
-
项目类别:
-
资助金额:$338.93万
-
财政年份:2012
-
负责人:MARY R GALINSKI
-
依托单位:
Plasmodium cynomolgi as a model for P. vivax.
-
批准号:8290557
-
项目类别:
-
资助金额:$17.6万
-
财政年份:2011
-
负责人:MARY R GALINSKI
-
依托单位:
RBL Binding Domain Malaria Candidate Vaccines
-
批准号:8104854
-
项目类别:
-
资助金额:$30.8万
-
财政年份:2011
-
负责人:MARY R GALINSKI
-
依托单位:
RETICULOCYTE BINDING-LIKE (RBL) PROTEINS AS NEW GENERATION MALARIA VACCINES
-
批准号:8357495
-
项目类别:
-
资助金额:$4.12万
-
财政年份:2011
-
负责人:MARY R GALINSKI
-
依托单位:
MOLECULAR ANALYSIS OF PLASMODIUM VIVAX SURFACE ANTIGENS
-
批准号:8357395
-
项目类别:
-
资助金额:$4.12万
-
财政年份:2011
-
负责人:MARY R GALINSKI
-
依托单位:
RBL Binding Domain Malaria Candidate Vaccines
-
批准号:8231986
-
项目类别:
-
资助金额:$17.6万
-
财政年份:2011
-
负责人:MARY R GALINSKI
-
依托单位:
MOLECULAR BASIS OF ANTIGENIC VARIATION ON MALARIA
-
批准号:8357390
-
项目类别:
-
资助金额:$4.12万
-
财政年份:2011
-
负责人:MARY R GALINSKI
-
依托单位:
Plasmodium cynomolgi as a model for P. vivax.
-
批准号:8177389
-
项目类别:
-
资助金额:$30.8万
-
财政年份:2011
-
负责人:MARY R GALINSKI
-
依托单位:
PLASMODIUM VIVAX MSP-3 AND MSP-9 AS VACCINE IMMUNOGENS
-
批准号:8172356
-
项目类别:
-
资助金额:$5.48万
-
财政年份:2010
-
负责人:MARY R GALINSKI
-
依托单位:
RETICULOCYTE BINDING-LIKE (RBL) PROTEINS AS NEW GENERATION MALARIA VACCINES
-
批准号:8172457
-
项目类别:
-
资助金额:$5.48万
-
财政年份:2010
-
负责人:MARY R GALINSKI
-
依托单位:
MOLECULAR BASIS OF ANTIGENIC VARIATION ON MALARIA
-
批准号:8172319
-
项目类别:
-
资助金额:$5.48万
-
财政年份:2010
-
负责人:MARY R GALINSKI
-
依托单位:
MOLECULAR ANALYSIS OF PLASMODIUM VIVAX SURFACE ANTIGENS
-
批准号:7958128
-
项目类别:
-
资助金额:$5.48万
-
财政年份:2009
-
负责人:MARY R GALINSKI
-
依托单位:
PLASMODIUM VIVAX MSP-3 AND MSP-9 AS VACCINE IMMUNOGENS
-
批准号:7958164
-
项目类别:
-
资助金额:$5.48万
-
财政年份:2009
-
负责人:MARY R GALINSKI
-
依托单位:
MOLECULAR BASIS OF ANTIGENIC VARIATION ON MALARIA
-
批准号:7958121
-
项目类别:
-
资助金额:$5.48万
-
财政年份:2009
-
负责人:MARY R GALINSKI
-
依托单位:
MOLECULAR ANALYSIS OF PLASMODIUM VIVAX SURFACE ANTIGENS
-
批准号:7715693
-
项目类别:
-
资助金额:$3.56万
-
财政年份:2008
-
负责人:MARY R GALINSKI
-
依托单位:
MOLECULAR BASIS OF ANTIGENIC VARIATION ON MALARIA
-
批准号:7715686
-
项目类别:
-
资助金额:$3.56万
-
财政年份:2008
-
负责人:MARY R GALINSKI
-
依托单位:
PLASMODIUM VIVAX MSP-3 AND MSP-9 AS VACCINE IMMUNOGENS
-
批准号:7715738
-
项目类别:
-
资助金额:$3.56万
-
财政年份:2008
-
负责人:MARY R GALINSKI
-
依托单位:
MOLECULAR ANALYSIS OF PLASMODIUM VIVAX SURFACE ANTIGENS
-
批准号:7562536
-
项目类别:
-
资助金额:$3.95万
-
财政年份:2007
-
负责人:MARY R GALINSKI
-
依托单位:
MOLECULAR BASIS OF ANTIGENIC VARIATION ON MALARIA
-
批准号:7562529
-
项目类别:
-
资助金额:$3.95万
-
财政年份:2007
-
负责人:MARY R GALINSKI
-
依托单位:
PLASMODIUM VIVAX MSP-3 AND MSP-9 AS VACCINE IMMUNOGENS
-
批准号:7562592
-
项目类别:
-
资助金额:$3.95万
-
财政年份:2007
-
负责人:MARY R GALINSKI
-
依托单位:
海外基金